A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27850 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Luca Varinelli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Organoids, Pseudomyxoma Peritonei, Peritoneal Neoplasms, Cell Culture Techniques. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Accelerator Award 2019.
Abstract (Originalsprache)
Background and Objectives Few preclinical models of pseudomyxoma peritonei (PMP) have been developed, probably due to the tumor's low incidence and its peculiar characteristics of slow growth. Therefore, there is a need to develop more refined PMP models that better reflect its characteristics. The aim of the study is to develop a culture strategy to generate organoid models derived from PMP patient samples.
Methods
We followed a strategy based on combinatorial culture conditions that include the different factors essential for PMP growth and that mimic the microenvironment present in the patients.
Results
We cultured PMP samples in the presence of the various factors produced by the niche environment of PMP. We obtained 12 PMP organoid models, each of which grows under specific culture conditions. PMP‐derived organoids show long‐term expansion capacity and reproduce the genetic landscape and histological phenotype of the tumor of origin.
Conclusion
The organoids we developed faithfully reproduce the key features of PMP disease and will allow us to understand the biology of PMP. With them, we will be able to identify key regulatory networks that support PMP progression, providing a platform for multilevel preclinical testing, identify novel diagnostic biomarkers, and generate novel targets for patient treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Epigenomics Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.
- Peritoneal Surface Malignancies Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy.
- Cogentech Ltd. Benefit Corporation with a Sole Shareholder, Milan, Italy.
- 1st Pathology Division, Department of Phatology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- Translational Program, Stem Cells and Cancer Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Wellcome Trust Centre for Cell-Matrix Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Accelerator Award 2019
Zitieren
APA
Varinelli, L., Di Bella, M., Guaglio, M., Battistessa, D., Pisati, F., Cavalleri, T., Milione, M., Martínez-Quintanilla, J., Caswell, P. T., Baratti, D., Kusamura, S., Deraco, M., Gariboldi, M., & PMPnet Group (2024). A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27850
Vancouver
Varinelli L, Di Bella M, Guaglio M, Battistessa D, Pisati F, Cavalleri T, et al. A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27850
BibTeX
@article{Varinelli2024,
author = {Varinelli, Luca and Di Bella, Marzia and Guaglio, Marcello and Battistessa, Davide and Pisati, Federica and Cavalleri, Tommaso and Milione, Massimo and Martínez-Quintanilla, Jordi and Caswell, Patrick T and Baratti, Dario and Kusamura, Shigeki and Deraco, Marcello and Gariboldi, Manuela and PMPnet Group, PMPnet Group},
title = {A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27850}
}
EUVIMED